IRF9 and cancer: After the stimulation of cancer cells with IFN-I, the transcription factors signal transducer and activator of transcription (STAT)1 and STAT2 are phosphorylated, followed by heterodimer formation with phosphorylated STAT1 and STAT2, which, in combination with IRF9, translocates to the nucleus to activate its corresponding gene expression.